Increased Prevalence of Liver Fibrosis and HIV Viremia among Patients with HIV, HBV, and Tuberculosis in Botswana.
Africa
Botswana
hepatitis B virus
human immunodeficiency virus
tuberculosis
Journal
Pathogens (Basel, Switzerland)
ISSN: 2076-0817
Titre abrégé: Pathogens
Pays: Switzerland
ID NLM: 101596317
Informations de publication
Date de publication:
14 Nov 2020
14 Nov 2020
Historique:
received:
08
10
2020
revised:
11
11
2020
accepted:
11
11
2020
entrez:
18
11
2020
pubmed:
19
11
2020
medline:
19
11
2020
Statut:
epublish
Résumé
People with concomitant human immunodeficiency virus (HIV) and tuberculosis (TB) have an increased risk of hepatotoxic reactions due to antiretroviral therapy (ART) and anti-TB therapy (ATT). Concomitant hepatitis B virus (HBV) in these patients may lead to poorer health outcomes. To assess liver enzyme levels and immune response in adults with HIV, HBV, and TB, data from 300 antiretroviral-naïve people living with HIV (PLWHIV) were analyzed. The prevalence of HIV/HBV (cHIV/HBV) and HIV/TB (cHIV/TB) was 28% (95% CI: 23.0-33.4) and 10% (95% CI: 6.8-14.0), respectively. HIV/HBV/TB (cHIV/HBV/TB) prevalence was 5.3% (95% CI: 3.1-8.5). There was a statistically significant difference between the groups of participants in HIV viral load (
Identifiants
pubmed: 33202597
pii: pathogens9110950
doi: 10.3390/pathogens9110950
pmc: PMC7696587
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Wellcome Trust
ID : 218770/Z/19/Z
Pays : United Kingdom
Organisme : Sub-Saharan African Network for TB/HIV Research Excellence (SANTHE)
ID : DEL-15-006
Organisme : H3ABioNet
ID : U41HG006941
Références
PLoS One. 2015 Jul 28;10(7):e0134037
pubmed: 26218239
AIDS. 2010 Jun 19;24(10):1501-8
pubmed: 20505496
J Acquir Immune Defic Syndr. 2013 May 1;63(1):142-5
pubmed: 23364513
BMC Med. 2015 Apr 02;13:70
pubmed: 25889688
Epidemiol Infect. 2006 Apr;134(2):333-9
pubmed: 16490138
Virus Genes. 2019 Feb;55(1):33-42
pubmed: 30382563
Lancet Infect Dis. 2010 Jul;10(7):455-63
pubmed: 20610327
Genes (Basel). 2018 May 17;9(5):
pubmed: 29772814
AIDS Res Hum Retroviruses. 2015 Jul;31(7):723-30
pubmed: 25924728
Nat Rev Immunol. 2008 Sep;8(9):737-44
pubmed: 18728636
J Glob Infect Dis. 2015 Oct-Dec;7(4):151-6
pubmed: 26752869
AIDS Res Hum Retroviruses. 2013 Feb;29(2):226-30
pubmed: 22881387
Clin Infect Dis. 2006 Dec 15;43(12):1612-5
pubmed: 17109297
Ann Med Surg (Lond). 2020 May 16;55:148-158
pubmed: 32477514
BMC Res Notes. 2019 Nov 19;12(1):751
pubmed: 31744538
BMC Infect Dis. 2017 Nov 1;17(Suppl 1):706
pubmed: 29143625
Open Forum Infect Dis. 2016 Aug 16;3(3):ofw140
pubmed: 27800524
J Clin Diagn Res. 2017 Aug;11(8):DD04-DD06
pubmed: 28969126
Am J Trop Med Hyg. 2011 Aug;85(2):390-4
pubmed: 21813864
PLoS One. 2018 Jun 1;13(6):e0198711
pubmed: 29856867
J Acquir Immune Defic Syndr. 2017 Nov 1;76(3):298-302
pubmed: 29016448
BMC Immunol. 2019 Dec 5;20(1):45
pubmed: 31805857
BMC Infect Dis. 2018 May 8;18(1):214
pubmed: 29739341
Postgrad Med J. 2003 Jun;79(932):307-12
pubmed: 12840117
J Int AIDS Soc. 2017 Jun 23;20(1):21327
pubmed: 28691438
J Trop Med. 2017;2017:5629130
pubmed: 28828009
J Leukoc Biol. 2020 Apr;107(4):597-612
pubmed: 31965635
Liver Int. 2015 Jul;35(7):1886-92
pubmed: 25581487
Int Immunopharmacol. 2017 Jan;42:168-175
pubmed: 27915131
Int J Infect Dis. 2014 Nov;28:95-100
pubmed: 25218771
PLoS One. 2008 Mar 19;3(3):e1809
pubmed: 18350147
BMC Infect Dis. 2017 Jul 25;17(1):517
pubmed: 28743248
J Infect Dis. 2014 Jul 15;209 Suppl 3:S100-6
pubmed: 24966189
Clin Infect Dis. 2007 Feb 1;44(3):431-7
pubmed: 17205454
Medicine (Baltimore). 2020 Feb;99(9):e19341
pubmed: 32118769
BMJ Open. 2020 Mar 31;10(3):e032890
pubmed: 32234740
PLoS One. 2014 Feb 12;9(2):e88552
pubmed: 24533106
Clin Dev Immunol. 2012;2012:670957
pubmed: 22474480
PLoS One. 2017 Jun 7;12(6):e0179035
pubmed: 28591184